Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Activated Recombinant FVII in Spinal Surgery
NCT00102037Phase 2Completed
- Sponsor
- Novo Nordisk
- Start
- Jul 2004
- Primary completion
- Feb 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of coagulation factor VIIa, sponsored by Novo Nordisk. Started Jul 2004; status: completed.
02
Drugs
coagulation factor VIIa
Beyond the preview
Go deeper on NCT00102037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00102037.